MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association between changes in hippocampal volumes, cognition, and CSF markers in Parkinson’s Disease

S. Becker, O. Granert, C. Schulte, K. Brockmann, B. Roeben, M. Bode, M. Timmers, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

Meeting: 2023 International Congress

Abstract Number: 1539

Keywords: Cognitive dysfunction, Hippocampus, Parkinson’s

Category: Parkinson's Disease: Neuroimaging

Objective: To assess whether changes in hippocampal subfield volumes are associated with cognition or CSF β-amyloid 1–42 (Aβ42) levels in Parkinson’s Disease (PD).

Background: Hippocampal structures are atrophic in people with PD, even in early disease stages. Cross-sectional data showed that cognitive, but not Aβ42, status was associated with volumes of the CA1 and hippocampal-amygdaloid-transition-area (HATA) [1]. To the best of our knowledge, nothing is known about the longitudinal course of these associations.

Method: Twenty-nine non-demented patients with PD underwent imaging and neuropsychological assessments at an interval of 2.02±0.09 years. CSF was collected at baseline; pathological Aβ42 levels were defined as <600 pg/mL. Cognitive status was classified using the Montreal Cognitive Assessment [<26=mild cognitive impairment (PD-MCI)]. Hippocampal volumes were segmented into 12 subfields using FreeSurfer 6.0 and corrected for intracranial volume at each visit. Repeated measures analyses of covariance examined the relationship between each corrected hippocampal subfield, time, and either baseline cognitive or Aβ42 status as predictors, covarying for baseline disease duration. Change in corrected hippocampal volumes was correlated with neuropsychological change scores (Repeatable Battery for the Assessment of Neuropsychological Status, RBANS, cognitive index scores) between visits (follow-up–baseline).

Results: Of all patients, 11 (37.9%) were classified as PD-MCI. Regarding Aβ42 status, 16 (55.2%) patients had pathological levels. Only the CA3 region showed a significant interaction where patients with normal baseline Aβ42 levels (n=8) had reductions in CA3 volumes over time [F(1,27)=4.24, p=.045, partial η2=.15]; no other interactions or main effects were observed. Worsening of RBANS immediate memory performance was significantly correlated with volumetric decline in the granule cell layer of the dentate gyrus (GC-DG) and CA4 (.46≤r≤.56, p<0.01). Improvements in the visuospatial index were associated with volumetric reductions in GC-DG, CA4, and HATA (-.52≤r≤-.39, p<0.04), and the attention index with CA3 regions (r=-.39 p=.034).

Conclusion: Normal baseline Aβ42 levels were associated with more pronounced degeneration of the CA3 region. However, we could not detect an association of Aβ42 levels and volumes of CA1 or HATA, as hypothesized. Memory and certain hippocampal subfields may decline in parallel.

References: [1] Becker S, Granert O, Timmers M, et al. Association of Hippocampal Subfields, CSF Biomarkers, and Cognition in Patients With Parkinson Disease Without Dementia. Neurology. 2021;96(6):e904-e915. doi:10.1212/WNL.0000000000011224

To cite this abstract in AMA style:

S. Becker, O. Granert, C. Schulte, K. Brockmann, B. Roeben, M. Bode, M. Timmers, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone. Association between changes in hippocampal volumes, cognition, and CSF markers in Parkinson’s Disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/association-between-changes-in-hippocampal-volumes-cognition-and-csf-markers-in-parkinsons-disease/. Accessed May 24, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-between-changes-in-hippocampal-volumes-cognition-and-csf-markers-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley